STIM1 and STING-associated vasculopathy with onset in infancy: The Ca2+ sensor stromal interaction molecule 1 (STIM1) has been reported to be a promising target for the treatment of SAVI, where STIM1 directly interacts with STING and inhibits the transport of STING from the ER to the Golgi apparatus (92).